A case report of renal inflammatory myofibroblastic tumor and renomedullary interstitial cell tumor
10.3760/cma.j.cn112330-20200816-00600
- VernacularTitle:肾盂炎性肌纤维母细胞瘤合并肾髓质间质细胞瘤1例报告
- Author:
Jibiao LI
1
;
Kaiwen LI
;
Hao LIU
;
Tianxin LIN
;
Wenlian XIE
;
Jian HUANG
Author Information
1. 中山大学孙逸仙纪念医院泌尿外科，广州 510120
- Keywords:
Kidney neoplasms;
Inflammatory myofibroblastic tumor;
Renomedullary interstitial cell tumor;
Pathology;
Prognosis
- From:
Chinese Journal of Urology
2022;43(3):217-218
- CountryChina
- Language:Chinese
-
Abstract:
Inflammatory myofibroblastic tumor (IMT)is a potentially or low-grade malignant mesenchymal neoplasm, which is rare in clinic. Renomedullary interstitial cell tumor(RICT) is a clinically rare benign renal tumor. The combination of these two diseases in one patient has not been reported. A 25-year-old female patient was admitted to the hospital due to left back pain for 12 days and hematuria for 1 week. MRI of kidneys showed a mass in the left renal pelvis, which was considered as renal pelvic carcinoma. Urine cytopathological examination was negative. Robot-assisted laparoscopic radical left nephroureterectomy was performed. There was no tumor recurrence or metastasis during the follow-up for more than 6 months after operation.
